bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Table S7 from NF1 Inactivation in Adult Acute Myelogenous Leukemia
Authors: Parkin Brian , Ouillette Peter , Wang Yin , Liu Yan , Wright Whitney , Roulston Diane , Purkayastha Anjali , Dressel Amanda , Karp Judith , Bockenstedt Paula , Al-Zoubi Ammar , Talpaz Moshe , Kujawski Lisa , Liu Yang , Shedden Kerby , Shakhan Sajid , Li Cheng , Erba Harry , Malek Sami N.
Published: April 2023

Supplementary Table S7 from NF1 Inactivation in Adult Acute Myelogenous Leukemia
Supplementary Data from Influence of Oct1/Oct2-Deficiency on Cisplatin-Induced Changes in Urinary N-Acetyl-β-D-Glucosaminidase
Authors: Franke Ryan M. , Kosloske Ashley M. , Lancaster Cynthia S. , Filipski Kelly K. , Hu Chaoxin , Zolk Oliver , Mathijssen Ron H. , Sparreboom Alex
Published: April 2023

Supplementary Figures S1-S2.
Supplementary Data from Chondroitinase ABC I–Mediated Enhancement of Oncolytic Virus Spread and Antitumor Efficacy
Authors: Dmitrieva Nina , Yu Lianbo , Viapiano Mariano , Cripe Timothy P. , Chiocca E. Antonio , Glorioso Joseph C. , Kaur Balveen
Published: April 2023

Supplementary Figures S1-S3.
Supplementary Data from Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization–Based Case-Control Study
Authors: Katz Ruth L. , He Weigong , Khanna Abha , Fernandez Ricardo L. , Zaidi Tanweer M. , Krebs Matthew , Caraway Nancy P. , Zhang Hua-Zhong , Jiang Feng , Spitz Margaret R. , Blowers David P. , Jimenez Carlos A. , Mehran Reza J. , Swisher Stephen G. , Roth Jack A. , Morris Jeffrey S. , Etzel Carol J. , El-Zein Randa
Published: April 2023

Supplementary Data from Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization–Based Case-Control Study
Supplementary Data from Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial
Authors: Carthon Bradley C. , Wolchok Jedd D. , Yuan Jianda , Kamat Ashish , Ng Tang Derek S. , Sun Jingjing , Ku Geoffrey , Troncoso Patricia , Logothetis Christopher J. , Allison James P. , Sharma Padmanee
Published: April 2023

Supplementary Data from Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial
Supplementary Data from AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer
Authors: Hickinson D. Mark , Klinowska Teresa , Speake Georgina , Vincent John , Trigwell Cath , Anderton Judith , Beck Sarah , Marshall Gayle , Davenport Sara , Callis Rowena , Mills Elizabeth , Grosios Konstantina , Smith Paul , Barlaam Bernard , Wilkinson Robert W. , Ogilvie Donald
Published: April 2023

Supplementary Data from AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer
Supplementary Table 2 from Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition
Authors: Allen Elizabeth , Walters Ian B. , Hanahan Douglas
Published: April 2023

PDF file - 66K
Supplementary Methods, Legends for Figures 1-4 and Tables 1-2 from Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition
Authors: Allen Elizabeth , Walters Ian B. , Hanahan Douglas
Published: April 2023

PDF file - 62K
Supplementary Figure 2 from T-Cell Immune Function in Tumor, Skin, and Peripheral Blood of Advanced Stage Melanoma Patients: Implications for Immunotherapy
Authors: Tjin Esther P.M. , Konijnenberg Debby , Krebbers Gabrielle , Mallo Henk , Drijfhout Jan W. , Franken Kees L.M.C. , van der Horst Chantal M.A.M. , Bos Jan D. , Nieweg Omgo E. , Kroon Bin B.R. , Haanen John B.A.G. , Melief Cornelis J.M. , Vyth-Dreese Florry A. , Luiten Rosalie M.
Published: April 2023

PDF file - 4689K
Supplementary Figure 1 from Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition
Authors: Allen Elizabeth , Walters Ian B. , Hanahan Douglas
Published: April 2023

PDF file - 112K
Supplementary Data 1 from Merkel Cell Polyomavirus Infection, Large T Antigen, Retinoblastoma Protein and Outcome in Merkel Cell Carcinoma
Authors: Sihto Harri , Kukko Heli , Koljonen Virve , Sankila Risto , Böhling Tom , Joensuu Heikki
Published: April 2023

Supplementary Data 1 from Merkel Cell Polyomavirus Infection, Large T Antigen, Retinoblastoma Protein and Outcome in Merkel Cell Carcinoma
Supplementary Data from Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, a Biomarker with Prognostic Specificity for Luminal B-Type Breast Cancer
Authors: Pettersson Filippa , Yau Christina , Dobocan Monica C. , Culjkovic-Kraljacic Biljana , Retrouvay Hélène , Puckett Rachel , Flores Ludmila M. , Krop Ian E. , Rousseau Caroline , Cocolakis Eftihia , Borden Katherine L. B. , Benz Christopher C. , Miller Wilson H.
Published: April 2023

Supplementary Figures S1-S4; Supplementary Table S1.
Supplementary Data from In vitro and In vivo Radiation Sensitization of Human Tumor Cells by a Novel Checkpoint Kinase Inhibitor, AZD7762
Authors: Mitchell James B. , Choudhuri Rajani , Fabre Kristin , Sowers Anastasia L. , Citrin Deborah , Zabludoff Sonya D. , Cook John A.
Published: April 2023

Supplementary Data from In vitro and In vivo Radiation Sensitization of Human Tumor Cells by a Novel Checkpoint Kinase Inhibitor, AZD7762
Supplementary Data from Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor
Authors: Bourdeaut Franck , Lequin Delphine , Brugières Laurence , Reynaud Stéphanie , Dufour Christelle , Doz François , André Nicolas , Stephan Jean-Louis , Pérel Yves , Oberlin Odile , Orbach Daniel , Bergeron Christophe , Rialland Xavier , Fréneaux Paul , Ranchere Dominique , Figarella-Branger Dominique , Audry Georges , Puget Stéphanie , Evans D. Gareth , Pinas Joan Carles Ferreres , Capra Valeria , Mosseri Véronique , Coupier Isabelle , Gauthier-Villars Marion , Pierron Gaëlle , Delattre Olivier
Published: April 2023

Supplementary Figure S1; Supplementary Table S1.
Supplementary Figure 1 from Dual Kinase Inhibition of EGFR and HER2 Overcomes Resistance to Cetuximab in a Novel In Vivo Model of Acquired Cetuximab Resistance
Authors: Quesnelle Kelly M. , Grandis Jennifer R.
Published: April 2023

PDF file - 166K
Supplementary Data from Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells
Authors: Wang Lihua H. , Pfister Thomas D. , Parchment Ralph E. , Kummar Shivaani , Rubinstein Larry , Evrard Yvonne A. , Gutierrez Martin E. , Murgo Anthony J. , Tomaszewski Joseph E. , Doroshow James H. , Kinders Robert J.
Published: April 2023

Supplementary Data from Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells
Supplementary Data from Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors
Authors: Sempere Lorenzo F. , Preis Meir , Yezefski Todd , Ouyang Haoxu , Suriawinata Arief A. , Silahtaroglu Asli , Conejo-Garcia Jose R. , Kauppinen Sakari , Wells Wendy , Korc Murray
Published: April 2023

Supplementary Figures S1-S7 and Supplementary Tables S1-S3.
Supplementary Figure 1 from Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates FIP1-like-1 Platelet-Derived Growth Factor Receptor α and Bcr-Abl Oncogene Addiction in Malignant Hematologic Cells
Authors: Wu Yongbin , Chen Chun , Sun Xiaoyong , Shi Xianping , Jin Bei , Ding Ke , Yeung Sai-Ching Jim , Pan Jingxuan
Published: April 2023

PDF file - 187K
Supplementary Figure Legends 1-8 from Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
Authors: Azim Hatem A. , Michiels Stefan , Bedard Philippe L. , Singhal Sandeep K. , Criscitiello Carmen , Ignatiadis Michail , Haibe-Kains Benjamin , Piccart Martine J. , Sotiriou Christos , Loi Sherene
Published: April 2023

PDF file - 62K
Supplementary Figure 1 from MARCKS Regulates Growth and Radiation Sensitivity and Is a Novel Prognostic Factor for Glioma
Authors: Jarboe John S. , Anderson Joshua C. , Duarte Christine W. , Mehta Tapan , Nowsheen Somaira , Hicks Patricia H. , Whitley Alexander C. , Rohrbach Timothy D. , McCubrey Raymond O. , Chiu Sherard , Burleson Tamara M. , Bonner James A. , Gillespie G. Yancey , Yang Eddy S. , Willey Christopher D.
Published: April 2023

PDF file, 24KB, Supplemental Figure S1 shows GBM cell line proliferation data.
Supplementary Figure 3 from Pharmacokinetic Dose-Scheduling Study of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors
Authors: LoRusso Patricia M. , Jimeno Antonio , Dy Grace , Adjei Alex , Berlin Jordan , Leichman Lawrence , Low Jennifer A. , Colburn Dawn , Chang Ilsung , Cheeti Sravanthi , Jin Jin Y. , Graham Richard A.
Published: April 2023

PDF file - 420K
Supplementary Figure 1 from Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
Authors: Azim Hatem A. , Michiels Stefan , Bedard Philippe L. , Singhal Sandeep K. , Criscitiello Carmen , Ignatiadis Michail , Haibe-Kains Benjamin , Piccart Martine J. , Sotiriou Christos , Loi Sherene
Published: April 2023

PDF file - 92K
Supplementary Figure 1 from Pharmacokinetic Dose-Scheduling Study of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors
Authors: LoRusso Patricia M. , Jimeno Antonio , Dy Grace , Adjei Alex , Berlin Jordan , Leichman Lawrence , Low Jennifer A. , Colburn Dawn , Chang Ilsung , Cheeti Sravanthi , Jin Jin Y. , Graham Richard A.
Published: April 2023

PDF file - 79K
Supplementary Figure 1 from Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features
Authors: Tzelepi Vassiliki , Zhang Jiexin , Lu Jing-Fang , Kleb Brittany , Wu Guanglin , Wan Xinhai , Hoang Anh , Efstathiou Eleni , Sircar Kanishka , Navone Nora M. , Troncoso Patricia , Liang Shoudan , Logothetis Christopher J. , Maity Sankar N. , Aparicio Ana M.
Published: April 2023

PDF file - 180K, A, Growth rate of MDA PCA 144-13, 146-10, 155-2, 170-4 and 180-30 xenografts. Note that the MDA PCA 144-13 xenograft line displays a large amount of necrosis. B. Diagram illustrates unsupervised hierarchal clustering using complete linkage and Pearson's correlation coefficient analysis of the raw expression profiles of androgen receptor-positive adenocarcinoma (MDA PCA 130, 117-9, 79) and androgen receptor-negative SCPC/LCNEC (MDA PCA 146-10, 155-2, 155-12, 144-13, 144-4) xenografts obtained with Affymetrix HGU133Plus2 array. In red are samples assessed on 1 day and in blue, those assessed on a different day. B, diagram illustrates Gene Ontology analysis results showing enrichment in biologic-process subtrees related to mitosis among the differently expressed genes. The biological processes that reached statistical significance are highlighted in red. SCPC, small-cell prostate carcinoma; LCNEC, large-cell neuroendocrine carcinoma.
Supplementary Figure 5 from The Prognostic Significance of Various 13q14 Deletions in Chronic Lymphocytic Leukemia
Authors: Ouillette Peter , Collins Roxane , Shakhan Sajid , Li Jinghui , Li Cheng , Shedden Kerby , Malek Sami N.
Published: April 2023

PDF file - 424KB
Supplementary Figure 3 from The Prognostic Significance of Various 13q14 Deletions in Chronic Lymphocytic Leukemia
Authors: Ouillette Peter , Collins Roxane , Shakhan Sajid , Li Jinghui , Li Cheng , Shedden Kerby , Malek Sami N.
Published: April 2023

PDF file - 434KB
Supplementary Tables S1-S2 from β-Catenin Activation Is Associated with Specific Clinical and Pathologic Characteristics and a Poor Outcome in Adrenocortical Carcinoma
Authors: Gaujoux Sébastien , Grabar Sophie , Fassnacht Martin , Ragazzon Bruno , Launay Pierre , Libé Rossella , Chokri Ilham , Audebourg Anne , Royer Benedict , Sbiera Silviu , Vacher-Lavenu Marie-Cécile , Dousset Bertrand , Bertagna Xavier , Allolio Bruno , Bertherat Jérôme , Tissier Frédérique
Published: April 2023

Supplementary Tables S1-S2.
Supplementary Figure 2 from The Prognostic Significance of Various 13q14 Deletions in Chronic Lymphocytic Leukemia
Authors: Ouillette Peter , Collins Roxane , Shakhan Sajid , Li Jinghui , Li Cheng , Shedden Kerby , Malek Sami N.
Published: April 2023

PDF file - 335KB
Supplementary Figure 1 from Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab–Docetaxel Treatment
Authors: Tinhofer Ingeborg , Klinghammer Konrad , Weichert Wilko , Knödler Maren , Stenzinger Albrecht , Gauler Thomas , Budach Volker , Keilholz Ulrich
Published: April 2023

PDF file - 70K
Supplementary Table 3 from Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer
Authors: Shimamura Takeshi , Perera Samanthi A. , Foley Kevin P. , Sang Jim , Rodig Scott J. , Inoue Takayo , Chen Liang , Li Danan , Carretero Julian , Li Yu-Chen , Sinha Papiya , Carey Christopher D. , Borgman Christa L. , Jimenez John-Paul , Meyerson Matthew , Ying Weiwen , Barsoum James , Wong Kwok-Kin , Shapiro Geoffrey I.
Published: April 2023

PDF file, 361K, Comparison of EGFR TKI and HSP90 inhibitor efficacy in Ba/F3 cells ectopically expressing different EGFR mutations.
Supplementary Table 1 from Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer
Authors: Shimamura Takeshi , Perera Samanthi A. , Foley Kevin P. , Sang Jim , Rodig Scott J. , Inoue Takayo , Chen Liang , Li Danan , Carretero Julian , Li Yu-Chen , Sinha Papiya , Carey Christopher D. , Borgman Christa L. , Jimenez John-Paul , Meyerson Matthew , Ying Weiwen , Barsoum James , Wong Kwok-Kin , Shapiro Geoffrey I.
Published: April 2023

PDF file, 560K, Comparison of ganetespib and 17-AAG efficacy in NSCLC cell lines.
Supplementary Figure 6 from Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer
Authors: Shimamura Takeshi , Perera Samanthi A. , Foley Kevin P. , Sang Jim , Rodig Scott J. , Inoue Takayo , Chen Liang , Li Danan , Carretero Julian , Li Yu-Chen , Sinha Papiya , Carey Christopher D. , Borgman Christa L. , Jimenez John-Paul , Meyerson Matthew , Ying Weiwen , Barsoum James , Wong Kwok-Kin , Shapiro Geoffrey I.
Published: April 2023

PDF file, 776K, Effects of 17-AAG and ganetespib on cell viability and mutant ERBB2 expression in ERBB2-dependent Ba/F3 cells.
Supplementary Table 2 from A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951
Authors: van den Bent Martin J. , Gravendeel Lonneke A. , Gorlia Thierry , Kros Johan M. , Lapre Lariesa , Wesseling Pieter , Teepen Johannes L. , Idbaih Ahmed , Sanson Marc , Smitt Peter A.E. Sillevis , French Pim J.
Published: April 2023

PDF file - 73KB, Correlation between clinical and molecular markers.
Supplementary Table 1 from A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951
Authors: van den Bent Martin J. , Gravendeel Lonneke A. , Gorlia Thierry , Kros Johan M. , Lapre Lariesa , Wesseling Pieter , Teepen Johannes L. , Idbaih Ahmed , Sanson Marc , Smitt Peter A.E. Sillevis , French Pim J.
Published: April 2023

PDF file - 50KB, Comparison of baseline characteristics.
Supplementary Figure 4 from A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951
Authors: van den Bent Martin J. , Gravendeel Lonneke A. , Gorlia Thierry , Kros Johan M. , Lapre Lariesa , Wesseling Pieter , Teepen Johannes L. , Idbaih Ahmed , Sanson Marc , Smitt Peter A.E. Sillevis , French Pim J.
Published: April 2023

PDF file - 2424KB
Supplementary Figure 3 from Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer
Authors: Shimamura Takeshi , Perera Samanthi A. , Foley Kevin P. , Sang Jim , Rodig Scott J. , Inoue Takayo , Chen Liang , Li Danan , Carretero Julian , Li Yu-Chen , Sinha Papiya , Carey Christopher D. , Borgman Christa L. , Jimenez John-Paul , Meyerson Matthew , Ying Weiwen , Barsoum James , Wong Kwok-Kin , Shapiro Geoffrey I.
Published: April 2023

PDF file, 365K, Activity of ganetespib in HCC827 xenografts.
Supplementary Figure 1 from Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer
Authors: Shimamura Takeshi , Perera Samanthi A. , Foley Kevin P. , Sang Jim , Rodig Scott J. , Inoue Takayo , Chen Liang , Li Danan , Carretero Julian , Li Yu-Chen , Sinha Papiya , Carey Christopher D. , Borgman Christa L. , Jimenez John-Paul , Meyerson Matthew , Ying Weiwen , Barsoum James , Wong Kwok-Kin , Shapiro Geoffrey I.
Published: April 2023

PDF file, 1349K, Depletion of receptor tyrosine kinases and suppression of downstream signaling in HCC827 cells in response to 17-AAG or ganetespib-mediated HSP90 inhibition.
Supplementary Table 1 from Frequency of Driver Mutations in Lung Adenocarcinoma from Female Never-Smokers Varies with Histologic Subtypes and Age at Diagnosis
Authors: Zhang Yang , Sun Yihua , Pan Yunjian , Li Chenguang , Shen Lei , Li Yuan , Luo Xiaoyang , Ye Ting , Wang Rui , Hu Haichuan , Li Hang , Wang Lei , Pao William , Chen Haiquan
Published: April 2023

PDF file - 142K
Supplementary Table 5 from Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
Authors: Zhu Yinghua , Yu Fengyan , Jiao Yu , Feng Juan , Tang Wei , Yao Herui , Gong Chang , Chen Jianing , Su Fengxi , Zhang Yan , Song Erwei
Published: April 2023

PDF file - 63K
Supplementary Table 2 from Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90
Authors: Mehta Pramod P. , Whalen Pamela , Baxi Sangita M. , Kung Pei-Pei , Yamazaki Shinji , Yin Min-Jean
Published: April 2023

PDF file - 16K
Supplementary Table 1 from Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90
Authors: Mehta Pramod P. , Whalen Pamela , Baxi Sangita M. , Kung Pei-Pei , Yamazaki Shinji , Yin Min-Jean
Published: April 2023

PDF file - 11K
Supplementary Table 3 from Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
Authors: Zhu Yinghua , Yu Fengyan , Jiao Yu , Feng Juan , Tang Wei , Yao Herui , Gong Chang , Chen Jianing , Su Fengxi , Zhang Yan , Song Erwei
Published: April 2023

PDF file - 123K
Supplementary Table 2 from Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
Authors: Zhu Yinghua , Yu Fengyan , Jiao Yu , Feng Juan , Tang Wei , Yao Herui , Gong Chang , Chen Jianing , Su Fengxi , Zhang Yan , Song Erwei
Published: April 2023

PDF file - 61K
Supplementary Table 1 from Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
Authors: Zhu Yinghua , Yu Fengyan , Jiao Yu , Feng Juan , Tang Wei , Yao Herui , Gong Chang , Chen Jianing , Su Fengxi , Zhang Yan , Song Erwei
Published: April 2023

PDF file - 66K
Supplementary Figure Legends 1-4 from Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
Authors: Zhu Yinghua , Yu Fengyan , Jiao Yu , Feng Juan , Tang Wei , Yao Herui , Gong Chang , Chen Jianing , Su Fengxi , Zhang Yan , Song Erwei
Published: April 2023

PDF file - 129K
Supplementary Figure 2 from Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90
Authors: Mehta Pramod P. , Whalen Pamela , Baxi Sangita M. , Kung Pei-Pei , Yamazaki Shinji , Yin Min-Jean
Published: April 2023

PDF file - 481K
Supplementary Figure 1 from Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90
Authors: Mehta Pramod P. , Whalen Pamela , Baxi Sangita M. , Kung Pei-Pei , Yamazaki Shinji , Yin Min-Jean
Published: April 2023

PDF file - 49K
Supplementary Figure 1 from Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
Authors: Zhu Yinghua , Yu Fengyan , Jiao Yu , Feng Juan , Tang Wei , Yao Herui , Gong Chang , Chen Jianing , Su Fengxi , Zhang Yan , Song Erwei
Published: April 2023

PDF file - 1.4MB
Supplementary Figure Legend from The Novel Chemical Entity YTR107 Inhibits Recruitment of Nucleophosmin to Sites of DNA Damage, Suppressing Repair of DNA Double-Strand Breaks and Enhancing Radiosensitization
Authors: Sekhar Konjeti R. , Reddy Yerramreddy Thirupathi , Reddy Penthala Narsimha , Crooks Peter A. , Venkateswaran Amudhan , McDonald William Hayes , Geng Ling , Sasi Soumya , Van Der Waal Robert P. , Roti Joseph L. Roti , Salleng Kenneth J. , Rachakonda Girish , Freeman Michael L.
Published: April 2023

PDF file - 46KB
Supplementary Table Legends 1-6 from Tumor Engraftment in Nude Mice and Enrichment in Stroma- Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer
Authors: Garrido-Laguna Ignacio , Uson Maria , Rajeshkumar N.V. , Tan Aik Choon , de Oliveira Elizabeth , Karikari Collins , Villaroel Maria C. , Salomon Ana , Taylor Gretchen , Sharma Rajni , Hruban Ralph H. , Maitra Anirban , Laheru Daniel , Rubio-Viqueira Belén , Jimeno Antonio , Hidalgo Manuel
Published: April 2023

PDF file - 115K
Related Article from New Treatments for Rhabdomyosarcoma: The Importance of Target Practice
Authors: Barr Frederic G.
Published: April 2023

Related Article from New Treatments for Rhabdomyosarcoma: The Importance of Target Practice
Supplementary Figure 2 from Tumor Engraftment in Nude Mice and Enrichment in Stroma- Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer
Authors: Garrido-Laguna Ignacio , Uson Maria , Rajeshkumar N.V. , Tan Aik Choon , de Oliveira Elizabeth , Karikari Collins , Villaroel Maria C. , Salomon Ana , Taylor Gretchen , Sharma Rajni , Hruban Ralph H. , Maitra Anirban , Laheru Daniel , Rubio-Viqueira Belén , Jimeno Antonio , Hidalgo Manuel
Published: April 2023

PDF file - 179K, Masson's trichrome staining showing that the desmoplastic reaction is preserved in orthotopic model while decreased in subcutaneous xenografts.
Supplementary Figure 1 from Tumor Engraftment in Nude Mice and Enrichment in Stroma- Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer
Authors: Garrido-Laguna Ignacio , Uson Maria , Rajeshkumar N.V. , Tan Aik Choon , de Oliveira Elizabeth , Karikari Collins , Villaroel Maria C. , Salomon Ana , Taylor Gretchen , Sharma Rajni , Hruban Ralph H. , Maitra Anirban , Laheru Daniel , Rubio-Viqueira Belén , Jimeno Antonio , Hidalgo Manuel
Published: April 2023

PDF file - 70K, We examined a gene signature of response to gemcitabine that included genes involved in the uptake (nucleoside transporters) and activation of gemcitabine (deoxycytin kinase) in tumor samples from patient JH034. We included samples from primary tumor, subcutaneous and orthotopic xenografts. Our analysis shows that primary and orthotopic xenografts are clustered together and differ from subcutaneous xenografts.
Supplementary Figure 1 from Molecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single Institution
Authors: Sylvester Brooke E. , Huo Dezheng , Khramtsov Andrey , Zhang Jing , Smalling Rana V. , Olugbile Sope , Polite Blase N. , Olopade Olufunmilayo I.
Published: April 2023

PDF file - 55K
Supplementary Table 1 from FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma
Authors: Crose Lisa E.S. , Etheridge Katherine T. , Chen Candy , Belyea Brian , Talbot Lindsay J. , Bentley Rex C. , Linardic Corinne M.
Published: April 2023

PDF file, 1842KB, STR profiles of human RMS cell lines used in this project and 2 Oligo sets used for RT-PCR, human FGFR4 cloning, and FGFR4 shRNAs.
Supplementary Figure 5 from FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma
Authors: Crose Lisa E.S. , Etheridge Katherine T. , Chen Candy , Belyea Brian , Talbot Lindsay J. , Bentley Rex C. , Linardic Corinne M.
Published: April 2023

PDF file, 1194KB, Pharmacologic inhibition of FGFRs blocks aRMS tumor growth in vivo.
Data Spreadsheet from Protein Profiling in Brain Tumors Using Mass Spectrometry
Authors: Schwartz Sarah A. , Weil Robert J. , Johnson Mahlon D. , Toms Steven A. , Caprioli Richard M.
Published: April 2023

Data Spreadsheet from Protein Profiling in Brain Tumors Using Mass Spectrometry
Supplementary Table 1 from GDC-0941, a Novel Class I Selective PI3K Inhibitor, Enhances the Efficacy of Docetaxel in Human Breast Cancer Models by Increasing Cell Death In Vitro and In Vivo
Authors: Wallin Jeffrey J. , Guan Jane , Prior Wei Wei , Lee Leslie B. , Berry Leanne , Belmont Lisa D. , Koeppen Hartmut , Belvin Marcia , Friedman Lori S. , Sampath Deepak
Published: April 2023

XLS file, 36KB, Summary of Breast Cancer Cell Growth Inhibition and Bliss Sums After Treatment with GDC-0941, Docetaxel (DTX) or the Combination of Both Drugs.
Supplementary Figure 3 from GDC-0941, a Novel Class I Selective PI3K Inhibitor, Enhances the Efficacy of Docetaxel in Human Breast Cancer Models by Increasing Cell Death In Vitro and In Vivo
Authors: Wallin Jeffrey J. , Guan Jane , Prior Wei Wei , Lee Leslie B. , Berry Leanne , Belmont Lisa D. , Koeppen Hartmut , Belvin Marcia , Friedman Lori S. , Sampath Deepak
Published: April 2023

PDF file, 125KB, Biomarkers for Cell Cycle Progression of HCC-1954 Cells After Synchronization Release.
Supplementary Tables 1-3 from Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy
Authors: Tonelli Roberto , McIntyre Alan , Camerin Consuelo , Walters Zoë S. , Di Leo Korinne , Selfe Joanna , Purgato Stefania , Missiaglia Edoardo , Tortori Andrea , Renshaw Jane , Astolfi Annalisa , Taylor Kathryn R. , Serravalle Salvatore , Bishop Ryan , Nanni Cristina , Valentijn Linda J. , Faccini Andrea , Leuschner Ivo , Formica Serena , Reis-Filho Jorge S. , Ambrosini Valentina , Thway Khin , Franzoni Monica , Summersgill Brenda , Marchelli Rosangela , Hrelia Patrizia , Cantelli-Forti Giorgio , Fanti Stefano , Corradini Roberto , Pession Andrea , Shipley Janet
Published: April 2023

PDF file - 62K
Supplementary Figure 1 from GDC-0941, a Novel Class I Selective PI3K Inhibitor, Enhances the Efficacy of Docetaxel in Human Breast Cancer Models by Increasing Cell Death In Vitro and In Vivo
Authors: Wallin Jeffrey J. , Guan Jane , Prior Wei Wei , Lee Leslie B. , Berry Leanne , Belmont Lisa D. , Koeppen Hartmut , Belvin Marcia , Friedman Lori S. , Sampath Deepak
Published: April 2023

PDF file, 89KB, FACS Analysis of HER2 Expression in MCF7-neo/HER2 Breast Cancer Cell Line.
Supplementary Data from Forkhead Transcription Factor FOXO1 is a Direct Target of Progestin to Inhibit Endometrial Epithelial Cell Growth
Authors: Kyo Satoru , Sakaguchi Junko , Kiyono Tohru , Shimizu Yutaka , Maida Yoshiko , Mizumoto Yasunari , Mori Noriko , Nakamura Mitsuhiro , Takakura Masahiro , Miyake Kiyohiko , Sakamoto Masaru , Inoue Masaki
Published: April 2023

Supplementary Figures S1-S3; Supplementary Table S1.
Supplementary Figure 5 from Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy
Authors: Tonelli Roberto , McIntyre Alan , Camerin Consuelo , Walters Zoë S. , Di Leo Korinne , Selfe Joanna , Purgato Stefania , Missiaglia Edoardo , Tortori Andrea , Renshaw Jane , Astolfi Annalisa , Taylor Kathryn R. , Serravalle Salvatore , Bishop Ryan , Nanni Cristina , Valentijn Linda J. , Faccini Andrea , Leuschner Ivo , Formica Serena , Reis-Filho Jorge S. , Ambrosini Valentina , Thway Khin , Franzoni Monica , Summersgill Brenda , Marchelli Rosangela , Hrelia Patrizia , Cantelli-Forti Giorgio , Fanti Stefano , Corradini Roberto , Pession Andrea , Shipley Janet
Published: April 2023

PDF file - 750K
Supplementary Figure 1 from A Noncanonical Flt3ITD/NF-κB Signaling Pathway Represses DAPK1 in Acute Myeloid Leukemia
Authors: Shanmugam Rajasubramaniam , Gade Padmaja , Wilson-Weekes Annique , Sayar Hamid , Suvannasankha Attaya , Goswami Chirayu , Li Lang , Gupta Sushil , Cardoso Angelo A. , Al Baghdadi Tareq , Sargent Katie J. , Cripe Larry D. , Kalvakolanu Dhananjaya V. , Boswell H. Scott
Published: April 2023

PDF file - 386K
Supplementary Tables 1 - 4 from Identification of Epstein-Barr Virus–Induced Gene 3 as a Novel Serum and Tissue Biomarker and a Therapeutic Target for Lung Cancer
Authors: Nishino Ryohei , Takano Atsushi , Oshita Hideto , Ishikawa Nobuhisa , Akiyama Hirohiko , Ito Hiroyuki , Nakayama Haruhiko , Miyagi Yohei , Tsuchiya Eiju , Kohno Nobuoki , Nakamura Yusuke , Daigo Yataro
Published: April 2023

PDF file - 148KB
Supplementary Figure 3 from Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy
Authors: Tonelli Roberto , McIntyre Alan , Camerin Consuelo , Walters Zoë S. , Di Leo Korinne , Selfe Joanna , Purgato Stefania , Missiaglia Edoardo , Tortori Andrea , Renshaw Jane , Astolfi Annalisa , Taylor Kathryn R. , Serravalle Salvatore , Bishop Ryan , Nanni Cristina , Valentijn Linda J. , Faccini Andrea , Leuschner Ivo , Formica Serena , Reis-Filho Jorge S. , Ambrosini Valentina , Thway Khin , Franzoni Monica , Summersgill Brenda , Marchelli Rosangela , Hrelia Patrizia , Cantelli-Forti Giorgio , Fanti Stefano , Corradini Roberto , Pession Andrea , Shipley Janet
Published: April 2023

PDF file - 242K
Supplementary Figures 1 - 2 from Identification of Epstein-Barr Virus–Induced Gene 3 as a Novel Serum and Tissue Biomarker and a Therapeutic Target for Lung Cancer
Authors: Nishino Ryohei , Takano Atsushi , Oshita Hideto , Ishikawa Nobuhisa , Akiyama Hirohiko , Ito Hiroyuki , Nakayama Haruhiko , Miyagi Yohei , Tsuchiya Eiju , Kohno Nobuoki , Nakamura Yusuke , Daigo Yataro
Published: April 2023

PDF file - 143KB
Supplementary Figures 1-6, Methods from Anti-VEGF Treatment–Resistant Pancreatic Cancers Secrete Proinflammatory Factors That Contribute to Malignant Progression by Inducing an EMT Cell Phenotype
Authors: Carbone Carmine , Moccia Tania , Zhu Cihui , Paradiso Genni , Budillon Alfredo , Chiao Paul J. , Abbruzzese James L. , Melisi Davide
Published: April 2023

PDF file - 298K
Supplementary Table 1 from Predictive Value of XRCC1 Gene Polymorphisms on Platinum-Based Chemotherapy in Advanced Non–Small Cell Lung Cancer Patients: A Systematic Review and Meta-analysis
Authors: Wu Junjie , Liu Jie , Zhou Yuhao , Ying Jun , Zou Houdong , Guo Shicheng , Wang Lei , Zhao Naiqing , Hu Jianjun , Lu Daru , Jin Li , Li Qiang , Wang Jiu-Cun
Published: April 2023

XLSX file, 12KB, Random effects OR with the corresponding 95% CI and heterogeneity results for multiple pairwise comparisons of XRCC1Trp194Arg and response rate to chemotherapy.
Supplementary Table 2 from BARD1 Expression Predicts Outcome in Colon Cancer
Authors: Sporn Judith C. , Hothorn Torsten , Jung Barbara
Published: April 2023

PDF file - 334K
Supplementary Video 1 from Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma
Authors: Kubo Takafumi , Toyooka Shinichi , Tsukuda Kazunori , Sakaguchi Masakiyo , Fukazawa Takuya , Soh Junichi , Asano Hiroaki , Ueno Tsuyoshi , Muraoka Takayuki , Yamamoto Hiromasa , Nasu Yasutomo , Kishimoto Takumi , Pass Harvey I. , Matsui Hideki , Huh Nam-ho , Miyoshi Shinichiro
Published: April 2023

AVI video file - 14709K, Example video file of automatically tracked H2052 cell line transfected with scramble control. The images were saved every minute, and cell movement was recorded with time-lapse video microscopy.
Supplementary Figure 1 from BARD1 Expression Predicts Outcome in Colon Cancer
Authors: Sporn Judith C. , Hothorn Torsten , Jung Barbara
Published: April 2023

PDF file - 1.08MB
Supplementary Figure 4 from Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma
Authors: Kubo Takafumi , Toyooka Shinichi , Tsukuda Kazunori , Sakaguchi Masakiyo , Fukazawa Takuya , Soh Junichi , Asano Hiroaki , Ueno Tsuyoshi , Muraoka Takayuki , Yamamoto Hiromasa , Nasu Yasutomo , Kishimoto Takumi , Pass Harvey I. , Matsui Hideki , Huh Nam-ho , Miyoshi Shinichiro
Published: April 2023

PDF file - 306K, Protein expression profile of MPM cell lines after transfection with Ad-miR-34b/c and Ad-Luc (control).
Supplementary Methods, Figures 1-4, Table Legends 1-14 from Characterization and Clinical Evaluation of CD10+ Stroma Cells in the Breast Cancer Microenvironment
Authors: Desmedt Christine , Majjaj Samira , Kheddoumi Naima , Singhal Sandeep K. , Haibe-Kains Benjamin , El Ouriaghli Frank , Chaboteaux Carole , Michiels Stefan , Lallemand Françoise , Journe Fabrice , Duvillier Hughes , Loi Sherene , Quackenbush John , Dekoninck Sophie , Blanpain Cédric , Lagneaux Laurence , Houhou Nawal , Delorenzi Mauro , Larsimont Denis , Piccart Martine , Sotiriou Christos
Published: April 2023

PDF file - 583K
Supplementary Data from Nitric Oxide–Donating Acetylsalicylic Acid Induces Apoptosis in Chronic Lymphocytic Leukemia Cells and Shows Strong Antitumor Efficacy In vivo
Authors: Razavi Regina , Gehrke Iris , Gandhirajan Rajesh Kumar , Poll-Wolbeck Simon Jonas , Hallek Michael , Kreuzer Karl-Anton
Published: April 2023

Supplementary Figures S1-S3; Supplementary Table S1.
Supplementary Table 4 from Colorectal Cancers with Microsatellite Instability Display Unique miRNA Profiles
Authors: Balaguer Francesc , Moreira Leticia , Lozano Juan Jose , Link Alexander , Ramirez Georgina , Shen Yan , Cuatrecasas Miriam , Arnold Mildred , Meltzer Stephen J. , Syngal Sapna , Stoffel Elena , Jover Rodrigo , Llor Xavier , Castells Antoni , Boland C. Richard , Gironella Meritxell , Goel Ajay
Published: April 2023

PDF file - 65K
CCR Translation for This Article from Resampling Phase III Data to Assess Phase II Trial Designs and Endpoints
Authors: Sharma Manish R. , Karrison Theodore G. , Jin Yuyan , Bies Robert R. , Maitland Michael L. , Stadler Walter M. , Ratain Mark J.
Published: April 2023

CCR Translation for This Article from Resampling Phase III Data to Assess Phase II Trial Designs and Endpoints
Supplementary Figures 1-5, Tables 1-2 from Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer
Authors: Doebele Robert C. , Pilling Amanda B. , Aisner Dara L. , Kutateladze Tatiana G. , Le Anh T. , Weickhardt Andrew J. , Kondo Kimi L. , Linderman Derek J. , Heasley Lynn E. , Franklin Wilbur A. , Varella-Garcia Marileila , Camidge D. Ross
Published: April 2023

PDF file - 58K
Supplementary Table 4 from Upregulation of Notch2 and Six1 Is Associated with Progression of Early-Stage Lung Adenocarcinoma and a More Aggressive Phenotype at Advanced Stages
Authors: Mimae Takahiro , Okada Morihito , Hagiyama Man , Miyata Yoshihiro , Tsutani Yasuhiro , Inoue Takao , Murakami Yoshinori , Ito Akihiko
Published: April 2023

PDF file - 172K
Flowchart of selection of articles from Statistical Issues and Recommendations for Noninferiority Trials in Oncology: A Systematic Review
Authors: Tanaka Shiro , Kinjo Yousuke , Kataoka Yoshiki , Yoshimura Kenichi , Teramukai Satoshi
Published: April 2023

PDF file - 50K
Supplementary Table 7 from MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias
Authors: Yu Jun , Li Ang , Hong Seung-Mo , Hruban Ralph H. , Goggins Michael
Published: April 2023

PDF file - 325K
Supplementary Table 6 from MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias
Authors: Yu Jun , Li Ang , Hong Seung-Mo , Hruban Ralph H. , Goggins Michael
Published: April 2023

PDF file - 273K
Supplementary Table 4 from MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias
Authors: Yu Jun , Li Ang , Hong Seung-Mo , Hruban Ralph H. , Goggins Michael
Published: April 2023

PDF file - 537K
Supplementary Tables 1-3 from Inhibition of the Notch-Hey1 Axis Blocks Embryonal Rhabdomyosarcoma Tumorigenesis
Authors: Belyea Brian C. , Naini Sarasija , Bentley Rex C. , Linardic Corinne M.
Published: April 2023

PDF file - 45K
Supplementary Figures Legends 1-2 from Inhibition of the Notch-Hey1 Axis Blocks Embryonal Rhabdomyosarcoma Tumorigenesis
Authors: Belyea Brian C. , Naini Sarasija , Bentley Rex C. , Linardic Corinne M.
Published: April 2023

PDF file - 55K
Supplementary Figure 1 from MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias
Authors: Yu Jun , Li Ang , Hong Seung-Mo , Hruban Ralph H. , Goggins Michael
Published: April 2023

PDF file - 170K
Supplementary Figures 1-8 from Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with MYB–NFIB Chimeric Fusion, MYB Expression, and Clinical Outcome
Authors: Mitani Yoshitsugu , Rao Pulivarthi H. , Futreal P. Andrew , Roberts Dianna B. , Stephens Philip J. , Zhao Yi-Jue , Zhang Li , Mitani Mutsumi , Weber Randal S. , Lippman Scott M. , Caulin Carlos , El-Naggar Adel K.
Published: April 2023

PDF file - 524K
Supplementary Table 1 from Phase I/II and Pharmacodynamic Study of Dovitinib (TKI258), an Inhibitor of Fibroblast Growth Factor Receptors and VEGF Receptors, in Patients with Advanced Melanoma
Authors: Kim Kevin B. , Chesney Jason , Robinson Douglas , Gardner Humphrey , Shi Michael M. , Kirkwood John M.
Published: April 2023

PDF file - 131K, Abbreviations: AUC0-t, area under the concentration-time curve from time zero to t; Cmax, maximum concentration; CV%, coefficient of variation; PK, pharmacokinetic; SD, standard deviation; T1/2, half-life.
Supplementary Data from KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy
Authors: Mortezavi Ashkan , Hermanns Thomas , Seifert Hans-Helge , Baumgartner Martin K. , Provenzano Maurizio , Sulser Tullio , Burger Maximilian , Montani Matteo , Ikenberg Kristian , Hofstädter Ferdinand , Hartmann Arndt , Jaggi Rolf , Moch Holger , Kristiansen Glen , Wild Peter J.
Published: April 2023

Supplementary Figures S1-S3; Supplementary Table S1.
Supplementary Materials and Methods from A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin κ C as a Compatible Prognostic Marker in Human Solid Tumors
Authors: Schmidt Marcus , Hellwig Birte , Hammad Seddik , Othman Amnah , Lohr Miriam , Chen Zonglin , Boehm Daniel , Gebhard Susanne , Petry Ilka , Lebrecht Antje , Cadenas Cristina , Marchan Rosemarie , Stewart Joanna D. , Solbach Christine , Holmberg Lars , Edlund Karolina , Kultima Hanna Göransson , Rody Achim , Berglund Anders , Lambe Mats , Isaksson Anders , Botling Johan , Karn Thomas , Müller Volkmar , Gerhold-Ay Aslihan , Cotarelo Christina , Sebastian Martin , Kronenwett Ralf , Bojar Hans , Lehr Hans-Anton , Sahin Ugur , Koelbl Heinz , Gehrmann Mathias , Micke Patrick , Rahnenführer Jörg , Hengstler Jan G.
Published: April 2023

PDF file - 76K
Supplementary Figure Legend from Characterization of a Cleavage Stimulation Factor, 3′ pre-RNA, Subunit 2, 64 kDa (CSTF2) as a Therapeutic Target for Lung Cancer
Authors: Aragaki Masato , Takahashi Koji , Akiyama Hirohiko , Tsuchiya Eiju , Kondo Satoshi , Nakamura Yusuke , Daigo Yataro
Published: April 2023

PDF file - 78K
Supplementary Figure 5 from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
Authors: Lu Hailing , Yang Yi , Gad Ekram , Inatsuka Carol , Wenner Cynthia A. , Disis Mary L. , Standish Leanna J.
Published: April 2023

PDF file - 83KB
Supplementary Figure 3 from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
Authors: Lu Hailing , Yang Yi , Gad Ekram , Inatsuka Carol , Wenner Cynthia A. , Disis Mary L. , Standish Leanna J.
Published: April 2023

PDF file - 82KB
Supplementary Figure 2 from Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial
Authors: Cheang Maggie C.U. , Voduc K. David , Tu Dongsheng , Jiang Shan , Leung Samuel , Chia Stephen K. , Shepherd Lois E. , Levine Mark N. , Pritchard Kathleen I. , Davies Sherri , Stijleman Inge J. , Davis Carole , Ebbert Mark T.W. , Parker Joel S. , Ellis Matthew J. , Bernard Philip S. , Perou Charles M. , Nielsen Torsten O.
Published: April 2023

PDF file - 270K
Supplementary Figure 1 from TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
Authors: Lu Hailing , Yang Yi , Gad Ekram , Inatsuka Carol , Wenner Cynthia A. , Disis Mary L. , Standish Leanna J.
Published: April 2023

PDF file - 69KB
Supplementary Table 1 from Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker
Authors: Pietanza M. Catherine , Kadota Kyuichi , Huberman Kety , Sima Camelia S. , Fiore John J. , Sumner Dyana K. , Travis William D. , Heguy Adriana , Ginsberg Michelle S. , Holodny Andrei I. , Chan Timothy A. , Rizvi Naiyer A. , Azzoli Christopher G. , Riely Gregory J. , Kris Mark G. , Krug Lee M.
Published: April 2023

PDF file - 39K
Supplementary Figure 2 from Mesothelin Overexpression Promotes Mesothelioma Cell Invasion and MMP-9 Secretion in an Orthotopic Mouse Model and in Epithelioid Pleural Mesothelioma Patients
Authors: Servais Elliot L. , Colovos Christos , Rodriguez Luis , Bograd Adam J. , Nitadori Jun-ichi , Sima Camelia , Rusch Valerie W. , Sadelain Michel , Adusumilli Prasad S.
Published: April 2023

PDF file - 1.3MB
Supplementary Methods, Figure 2 from New Gene-Immunotherapy Combining TRAIL-Lymphocytes and EpCAMxCD3 Bispecific Antibody for Tumor Targeting
Authors: Groth Ariane , Salnikov Alexei V. , Ottinger Sabine , Gladkich Jury , Liu Li , Kallifatidis Georgios , Salnikova Olga , Ryschich Eduard , Giese Nathalia , Giese Thomas , Momburg Frank , Büchler Markus W. , Moldenhauer Gerhard , Herr Ingrid
Published: April 2023

PDF file - 49K
Supplementary Figure 1 from Expression of FoxM1 Is Required for the Proliferation of Medulloblastoma Cells and Indicates Worse Survival of Patients
Authors: Priller Markus , Pöschl Julia , Abrão Leticia , von Bueren André O. , Cho Yoon-Jae , Rutkowski Stefan , Kretzschmar Hans A. , Schüller Ulrich
Published: April 2023

PDF file - 86KB
Supplementary Table 1 from Mast Cells in Tumor Microenvironment Promotes the In Vivo Growth of Pancreatic Ductal Adenocarcinoma
Authors: Chang David Z. , Ma Ying , Ji Baoan , Wang Huamin , Deng Defeng , Liu Yan , Abbruzzese James L. , Liu Yong-jun , Logsdon Craig D. , Hwu Patrick
Published: April 2023

PDF file - 78.8KB
CCR Translation for This Article from Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer
Authors: Kayani Irfan , Avril Norbert , Bomanji Jamshed , Chowdhury Simon , Rockall Andrea , Sahdev Anju , Nathan Paul , Wilson Peter , Shamash Jonathan , Sharpe Kevin , Lim Louise , Dickson John , Ell Peter , Reynolds Andrew , Powles Thomas
Published: April 2023

CCR Translation for This Article from Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer
Supplementary Figures S1-S12 from Nutlin-3a Is a Potential Therapeutic for Ewing Sarcoma
Authors: Pishas Kathleen I. , Al-Ejeh Fares , Zinonos Irene , Kumar Raman , Evdokiou Andreas , Brown Michael P. , Callen David F. , Neilsen Paul M.
Published: April 2023

Supplementary Figures S1-S12.
CCR Translation for This Article from DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non–Small Cell Lung Cancer
Authors: Walter Kim , Holcomb Thomas , Januario Tom , Du Pan , Evangelista Marie , Kartha Nithya , Iniguez Leonardo , Soriano Robert , Huw Ling , Stern Howard , Modrusan Zora , Seshagiri Somasekar , Hampton Garret M. , Amler Lukas C. , Bourgon Richard , Yauch Robert L. , Shames David S.
Published: April 2023

CCR Translation for This Article from DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non–Small Cell Lung Cancer
Supplementary Figure 5 from Dual mTORC1/2 and HER2 Blockade Results in Antitumor Activity in Preclinical Models of Breast Cancer Resistant to Anti-HER2 Therapy
Authors: García-García Celina , Ibrahim Yasir H. , Serra Violeta , Calvo Maria Teresa , Guzmán Marta , Grueso Judit , Aura Claudia , Pérez José , Jessen Katti , Liu Yi , Rommel Christian , Tabernero Josep , Baselga José , Scaltriti Maurizio
Published: April 2023

PDF file, 593KB, In vitro cell death induced by lapatinib and INK-128 of trastuzumab/lapatinib resistant cell lines.
Supplementary Table 7 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
Authors: Bullinger Lars , Schlenk Richard F. , Götz Marlies , Botzenhardt Ursula , Hofmann Susanne , Russ Annika C. , Babiak Anna , Zhang Lu , Schneider Vanessa , Döhner Konstanze , Schmitt Michael , Döhner Hartmut , Greiner Jochen
Published: April 2023

XLSX file - 77K, RNAi ATRA
Supplementary Table 2 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
Authors: Bullinger Lars , Schlenk Richard F. , Götz Marlies , Botzenhardt Ursula , Hofmann Susanne , Russ Annika C. , Babiak Anna , Zhang Lu , Schneider Vanessa , Döhner Konstanze , Schmitt Michael , Döhner Hartmut , Greiner Jochen
Published: April 2023

XLSX file - 120K, Class Comparison PRAME
Supplementary Figure 1 from Copy Number Losses Define Subgroups of Dedifferentiated Liposarcoma with Poor Prognosis and Genomic Instability
Authors: Crago Aimee M. , Socci Nicholas D. , DeCarolis Penelope , O'Connor Rachael , Taylor Barry S. , Qin Li-Xuan , Antonescu Cristina R. , Singer Samuel
Published: April 2023

PDF file - 32K, Genomic complexity in well and dedifferentiated liposarcoma.
SupplementaryTable 1 from Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas
Authors: Migliardi Giorgia , Sassi Francesco , Torti Davide , Galimi Francesco , Zanella Eugenia R. , Buscarino Michela , Ribero Dario , Muratore Andrea , Massucco Paolo , Pisacane Alberto , Risio Mauro , Capussotti Lorenzo , Marsoni Silvia , Di Nicolantonio Federica , Bardelli Alberto , Comoglio Paolo M. , Trusolino Livio , Bertotti Andrea
Published: April 2023

PDF file - 22K
Supplementary Figure 3B from Clinical Outcomes in Non–Small Cell Lung Cancers Harboring Different Exon 19 Deletions in EGFR
Authors: Chung Kuei-Pin , Wu Shang-Gin , Wu Jenn-Yu , Yang James Chih-Hsin , Yu Chong-Jen , Wei Pin-Fei , Shih Jin-Yuan , Yang Pan-Chyr
Published: April 2023

PDF file - 106K, Kaplan-Meier curves of PFS (A) and OS (B) were plotted for patients
Supplementary Figure 3A from Clinical Outcomes in Non–Small Cell Lung Cancers Harboring Different Exon 19 Deletions in EGFR
Authors: Chung Kuei-Pin , Wu Shang-Gin , Wu Jenn-Yu , Yang James Chih-Hsin , Yu Chong-Jen , Wei Pin-Fei , Shih Jin-Yuan , Yang Pan-Chyr
Published: April 2023

PDF file - 103K, Kaplan-Meier curves of PFS (A) and OS (B) were plotted for patients
Supplementary Table 1 from Polymeric Nanoparticle-Encapsulated Hedgehog Pathway Inhibitor HPI-1 (NanoHHI) Inhibits Systemic Metastases in an Orthotopic Model of Human Hepatocellular Carcinoma
Authors: Xu Yang , Chenna Venugopal , Hu Chaoxin , Sun Hai-Xiang , Khan Mehtab , Bai Haibo , Yang Xin-Rong , Zhu Qing-Feng , Sun Yun-Fan , Maitra Anirban , Fan Jia , Anders Robert A.
Published: April 2023

PDF file - 72KB